Business

Teva to pay $512 million in Provigil settlement – report

“Reuters” said the settlement would be the largest ever paid over allegations of delaying generic drugs.

Published

April 20, 2015

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has agreed to pay $512 million to settle a class action suit, reports “Reuters.” The class action claims that Cephalon Inc., which Teva bought in 2011, “used anticompetitive settlements to delay generic versions of its wakefulness drug Provigil, according to court papers, ” says “Reuters.”

–

Published by Globes [online], Israel business news – www.globes-online.com

In this article:Teva Pharmaceutical Industries Ltd.(NYSE: TEVA; TASE: TEVA), settlement, Finance

World News

Good News From Israel

In the 15th Nov 2015 edition of Israel’s good news, the highlights include: · A new Israeli treatment brings hope to relapsed leukemia...

Michael OrdmanNovember 15, 2015

Life-Style Health

Why search Dr. Google when you can hire a Real Personal Health Researcher?

Medint’s medical researchers provide data-driven insights to help patients make decisions; It is affordable- hundreds rather than thousands of dollars

Abigail Klein LeichmanFebruary 4, 2018

Religion

PURIM BREAKING: Donald Trump Converting to Judaism

He hopes to be a real Jew in time for Passover.

Gil TanenbaumFebruary 25, 2021

Leadership

Jews Make-Up 19% of Forbes 200 World’s Richest List

Jews are disproportionately represented on the roster of the richest business people, with 10 Jews among the top 50 (20%), and 38 (19%) Jews...

Alan GallindossMarch 7, 2018

Jewish Business News